Search research articles
Contact Us
Filters
Showing results (11-20 of 287) with videos related to
Page
of 29
Sort By:
Minerva Pediatrica
|
October 31, 1984
[Prolactin response to TRH in patients with idiopathic delayed puberty]
R Mauri, M Resentini, P Lissoni, et al.
Tumori
|
October 31, 1989
Evidence for altered hypothalamic-hypophyseal-gonadal axis in untreated patients with testicular germ-cell tumor
S Crispino, G Tancini, S Barni, et al.
The International Journal of Biological Markers
|
January 1, 1989
Prolactin secretion in testicular cancer patients
P Lissoni, S Crispino, S Barni, et al.
Oncology
|
January 1, 1991
Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report
P Lissoni, S Barni, F Rovelli, et al.
The International Journal of Biological Markers
|
July 10, 1999
Changes in lymphocyte number during cancer chemotherapy and their relation to clinical response
P Lissoni, L Fumagalli, F Paolorossi, et al.
Anticancer Research
|
August 6, 2000
A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies
P Lissoni, S Bolis, F Brivio, et al.
Oncology Reports
|
May 19, 2011
Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas
P Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers
|
April 1, 1997
Interleukin-4 blood concentrations in early and metastatic human solid neoplasms
P Lissoni, D Merlini, D Pirato, et al.
Journal of Biological Regulators and Homeostatic Agents
|
September 30, 1999
Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?
P Lissoni, F Brivio, S Viviani, et al.
The International Journal of Biological Markers
|
January 1, 1995
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patients
P Lissoni, S Barni, M G Grassi, et al.
Page
of 29
Search research articles
Search
Showing results (11-20 of 287) with videos related to
Sort By:
Page
of 29
Minerva Pediatrica
|
October 31, 1984
[Prolactin response to TRH in patients with idiopathic delayed puberty]
R Mauri, M Resentini, P Lissoni, et al.
Tumori
|
October 31, 1989
Evidence for altered hypothalamic-hypophyseal-gonadal axis in untreated patients with testicular germ-cell tumor
S Crispino, G Tancini, S Barni, et al.
The International Journal of Biological Markers
|
January 1, 1989
Prolactin secretion in testicular cancer patients
P Lissoni, S Crispino, S Barni, et al.
Oncology
|
January 1, 1991
Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report
P Lissoni, S Barni, F Rovelli, et al.
The International Journal of Biological Markers
|
July 10, 1999
Changes in lymphocyte number during cancer chemotherapy and their relation to clinical response
P Lissoni, L Fumagalli, F Paolorossi, et al.
Anticancer Research
|
August 6, 2000
A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies
P Lissoni, S Bolis, F Brivio, et al.
Oncology Reports
|
May 19, 2011
Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas
P Lissoni, S Barni, A Ardizzoia, et al.
The International Journal of Biological Markers
|
April 1, 1997
Interleukin-4 blood concentrations in early and metastatic human solid neoplasms
P Lissoni, D Merlini, D Pirato, et al.
Journal of Biological Regulators and Homeostatic Agents
|
September 30, 1999
Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?
P Lissoni, F Brivio, S Viviani, et al.
The International Journal of Biological Markers
|
January 1, 1995
Effects of granulocyte colony stimulating factor on the specific macrophage marker neopterin in cancer patients
P Lissoni, S Barni, M G Grassi, et al.
Page
of 29